USPTO serial 97489477
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Marc Cullen Goldsen
Marc Cullen Goldsen DAVIS MILES MCGUIRE GARDNER, PLLC40 EAST RIO SALADO PARKWAY, SUITE 425TEMPE, AZ 85281UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 044 | Stem cell therapy services; Aesthetician services; Cosmetic body care services; Cosmetic face care services; Cosmetic skin care services; Hair restoration services; Health care; Health care consulting in the field of regenerative medicine; Health care services for treating Achilles tears, aging disorders, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, ankle sprains, arthritis, autism, autoimmune diseases in the nature of rheumatoid arthritis (RA), lupus and psoriasis, back pain, cardiomyopathy, carpal tunnel syndrome, cartilage defects, chronic obstructive pulmonary disease (COPD), Complex Regional Pain Syndrome (CRPS), degenerative disc disease, diabetes, erectile dysfunction (ED), facet syndrome, failed back surgery syndrome (FBSS), fractures, headaches, heart failure, interstitial cystitis, joint pain, kidney failure, knee ligament injuries, lichen sclerosis, Lyme disease, migraines, multiple sclerosis (MS), neck pain, neuropathy, Parkinson's disease, pelvic pain, phantom limb pain, plantar fasciitis, post-herpetic neuralgia, post-laminectomy syndrome, pudendal neuralgia, reflex sympathetic dystrophy (RSD), rotator cuff tears, sacroiliac (SI) joint pain, sciatica, spinal stenosis, stroke, tendonitis, tension headaches, trigeminal neuralgia, and urinary incontinence; Health care services, namely, anti-aging therapies and treatments, collagen induction therapy, facial rejuvenation treatments, hormone replacement, hyperbaric oxygen therapy, intravenous wellness therapy, regenerative therapies, and analysis, diagnosis and treatment of Achilles tears, aging disorders, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, ankle sprains, arthritis, autism, autoimmune diseases such as rheumatoid arthritis (RA), lupus and psoriasis, back pain, cardiomyopathy, carpal tunnel syndrome, cartilage defects, chronic obstructive pulmonary disease (COPD), Complex Regional Pain Syndrome (CRPS), degenerative disc disease, diabetes, erectile dysfunction (ED), facet syndrome, failed back surgery syndrome (FBSS), fractures, headaches, heart failure, interstitial cystitis, joint pain, kidney failure, knee ligament injuries, lichen sclerosis, Lyme disease, migraines, multiple sclerosis (MS), neck pain, neuropathy, Parkinson's disease, pelvic pain, phantom limb pain, plantar fasciitis, post-herpetic neuralgia, post-laminectomy syndrome, pudendal neuralgia, reflex sympathetic dystrophy (RSD), rotator cuff tears, sacroiliac (SI) joint pain, sciatica, spinal stenosis, stroke, tendonitis, tension headaches, trigeminal neuralgia, and urinary incontinence; Health center services; Health clinic services; Health counseling; Medical diagnosis and treatment of Achilles tears, aging disorders, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, ankle sprains, arthritis, autism, autoimmune diseases such as rheumatoid arthritis (RA), lupus and psoriasis, back pain, cardiomyopathy, carpal tunnel syndrome, cartilage defects, chronic obstructive pulmonary disease (COPD), Complex Regional Pain Syndrome (CRPS), degenerative disc disease, diabetes, erectile dysfunction (ED), facet syndrome, failed back surgery syndrome (FBSS), fractures, headaches, heart failure, interstitial cystitis, joint pain, kidney failure, knee ligament injuries, lichen sclerosis, Lyme disease, migraines, multiple sclerosis (MS), neck pain, neuropathy, Parkinson's disease, pelvic pain, phantom limb pain, plantar fasciitis, post-herpetic neuralgia, post-laminectomy syndrome, pudendal neuralgia, reflex sympathetic dystrophy (RSD), rotator cuff tears, sacroiliac (SI) joint pain, sciatica, spinal stenosis, stroke, tendonitis, tension headaches, trigeminal neuralgia, and urinary incontinence; Medical services in the field of regenerative medicine; Medical services relating to the removal, treatment and processing of human cells; Medical services relating to the removal, treatment and processing of stem cells; Medical services, namely, anti-aging therapies and treatments, collagen induction therapy, facial rejuvenation treatments, hormone replacement, hyperbaric oxygen therapy, intravenous wellness therapy, regenerative therapies, and analysis, diagnosis and treatment of Achilles tears, aging disorders, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, ankle sprains, arthritis, autism, autoimmune diseases such as rheumatoid arthritis (RA), lupus and psoriasis, back pain, cardiomyopathy, carpal tunnel syndrome, cartilage defects, chronic obstructive pulmonary disease (COPD), Complex Regional Pain Syndrome (CRPS), degenerative disc disease, diabetes, erectile dysfunction (ED), facet syndrome, failed back surgery syndrome (FBSS), fractures, headaches, heart failure, interstitial cystitis, joint pain, kidney failure, knee ligament injuries, lichen sclerosis, Lyme disease, migraines, multiple sclerosis (MS), neck pain, neuropathy, Parkinson's disease, pelvic pain, phantom limb pain, plantar fasciitis, post-herpetic neuralgia, post-laminectomy syndrome, pudendal neuralgia, reflex sympathetic dystrophy (RSD), rotator cuff tears, sacroiliac (SI) joint pain, sciatica, spinal stenosis, stroke, tendonitis, tension headaches, trigeminal neuralgia, and urinary incontinence; Medical skin care services; Medical spa services, namely, minimally and non-invasive cosmetic and body fitness therapies; Medical testing for diagnostic or treatment purposes in the field of regenerative medicine; Medical treatment of Achilles tears, aging disorders, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, ankle sprains, arthritis, autism, autoimmune diseases such as rheumatoid arthritis (RA), lupus and psoriasis, back pain, cardiomyopathy, carpal tunnel syndrome, cartilage defects, chronic obstructive pulmonary disease (COPD), Complex Regional Pain Syndrome (CRPS), degenerative disc disease, diabetes, erectile dysfunction (ED), facet syndrome, failed back surgery syndrome (FBSS), fractures, headaches, heart failure, interstitial cystitis, joint pain, kidney failure, knee ligament injuries, lichen sclerosis, Lyme disease, migraines, multiple sclerosis (MS), neck pain, neuropathy, Parkinson's disease, pelvic pain, phantom limb pain, plantar fasciitis, post-herpetic neuralgia, post-laminectomy syndrome, pudendal neuralgia, reflex sympathetic dystrophy (RSD), rotator cuff tears, sacroiliac (SI) joint pain, sciatica, spinal stenosis, stroke, tendonitis, tension headaches, trigeminal neuralgia, and urinary incontinence using cultured cells; Medical treatment of Achilles tears, aging disorders, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, ankle sprains, arthritis, autism, autoimmune diseases such as rheumatoid arthritis (RA), lupus and psoriasis, back pain, cardiomyopathy, carpal tunnel syndrome, cartilage defects, chronic obstructive pulmonary disease (COPD), Complex Regional Pain Syndrome (CRPS), degenerative disc disease, diabetes, erectile dysfunction (ED), facet syndrome, failed back surgery syndrome (FBSS), fractures, headaches, heart failure, interstitial cystitis, joint pain, kidney failure, knee ligament injuries, lichen sclerosis, Lyme disease, migraines, multiple sclerosis (MS), neck pain, neuropathy, Parkinson's disease, pelvic pain, phantom limb pain, plantar fasciitis, post-herpetic neuralgia, post-laminectomy syndrome, pudendal neuralgia, reflex sympathetic dystrophy (RSD), rotator cuff tears, sacroiliac (SI) joint pain, sciatica, spinal stenosis, stroke, tendonitis, tension headaches, trigeminal neuralgia, and urinary incontinence; Medical treatment using cultured cells; Medical, hygienic and beauty care; Providing health and wellness information in the field of regenerative medicine via a website | ACTIVE | Aug 1, 2021 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 7, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 7, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 4, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 20, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 2, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 31, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 18, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 18, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 18, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 18, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 18, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 28, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 28, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 27, 2023 | ALIE | ASSIGNED TO LIE | — |
| Aug 2, 2023 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Aug 1, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 1, 2023 | PETG | PETITION TO REVIVE-GRANTED | — |
| Aug 1, 2023 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jul 31, 2023 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 30, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 30, 2023 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 6, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 6, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 6, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 28, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 25, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 8, 2022 | NWAP | NEW APPLICATION ENTERED | — |